{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:18:22Z","timestamp":1790806702480,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,12]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ezh2 is specifically required to induce effector cells producing IFN-\u03b3 and expansion of T cells late upon alloantigen activation. Genetic inactivation of Ezh2 function reduces GVHD but preserves antitumor effects in mice after allogeneic BMT.<\/jats:p>","DOI":"10.1182\/blood-2013-05-505180","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T01:39:19Z","timestamp":1382146759000},"page":"4119-4128","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":63,"title":["The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease"],"prefix":"10.1182","volume":"122","author":[{"given":"Shan","family":"He","sequence":"first","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongnian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Lapinski","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram-Shankar","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan Medical School, Ann Arbor, MI; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Mineishi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111816480549900_B1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy.","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"9674","key":"2019111816480549900_B2","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease.","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"2019111816480549900_B3","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes.","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"2019111816480549900_B4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-2776(06)90004-2","article-title":"Induction of tumor immunity following allogeneic stem cell transplantation.","volume":"90","author":"Wu","year":"2006","journal-title":"Adv Immunol"},{"issue":"12","key":"2019111816480549900_B5","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood.V98.12.3192","article-title":"The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.","volume":"98","author":"Ho","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2019111816480549900_B6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease.","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2019111816480549900_B7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation.","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111816480549900_B8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri2487","article-title":"Epigenetic control of T-helper-cell differentiation.","volume":"9","author":"Wilson","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2019111816480549900_B9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2217\/imt.13.101","article-title":"Histone methyltransferase and histone methylation in inflammatory T-cell responses.","volume":"5","author":"He","year":"2013","journal-title":"Immunotherapy"},{"issue":"5","key":"2019111816480549900_B10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2011-06-364422","article-title":"Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.","volume":"119","author":"He","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111816480549900_B11","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation.","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"2019111816480549900_B12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev"},{"issue":"4","key":"2019111816480549900_B13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrm3545","article-title":"Emerging roles for chromatin as a signal integration and storage platform.","volume":"14","author":"Badeaux","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7330","key":"2019111816480549900_B14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life.","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"issue":"5","key":"2019111816480549900_B15","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1182\/blood-2005-09-3585","article-title":"The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion.","volume":"107","author":"Kamminga","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2019111816480549900_B16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2005.02.029","article-title":"Polycomb group protein ezh2 controls actin polymerization and cell signaling.","volume":"121","author":"Su","year":"2005","journal-title":"Cell"},{"issue":"2","key":"2019111816480549900_B17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.","volume":"4","author":"Su","year":"2003","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111816480549900_B18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbmt.2010.01.012","article-title":"Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.","volume":"16","author":"Kato","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"2019111816480549900_B19","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2009-11-253559","article-title":"Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation.","volume":"115","author":"Shono","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111816480549900_B20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1172\/JCI39395","article-title":"The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.","volume":"120","author":"Na","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111816480549900_B21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.166.2.973","article-title":"Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.","volume":"166","author":"Suchin","year":"2001","journal-title":"J Immunol"},{"issue":"8","key":"2019111816480549900_B22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nri853","article-title":"Maintaining the norm: T-cell homeostasis.","volume":"2","author":"Jameson","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2019111816480549900_B23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"2019111816480549900_B24","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.0900592","article-title":"Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory.","volume":"183","author":"Agarwal","year":"2009","journal-title":"J Immunol"},{"issue":"7","key":"2019111816480549900_B25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nri2570","article-title":"CD95, BIM and T cell homeostasis.","volume":"9","author":"Bouillet","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2019111816480549900_B26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/cdd.2013.25","article-title":"Mcl-1 antagonizes Bax\/Bak to promote effector CD4(+) and CD8(+) T-cell responses.","volume":"20","author":"Tripathi","year":"2013","journal-title":"Cell Death Differ"},{"issue":"19","key":"2019111816480549900_B27","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1074\/jbc.M709886200","article-title":"Unconventional association of the polycomb group proteins with cytokine genes in differentiated T helper cells.","volume":"283","author":"Jacob","year":"2008","journal-title":"J Biol Chem"},{"issue":"36","key":"2019111816480549900_B28","doi-asserted-by":"crossref","first-page":"31470","DOI":"10.1074\/jbc.M504766200","article-title":"EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells.","volume":"280","author":"Koyanagi","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"2019111816480549900_B29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1182\/blood-2006-12-063982","article-title":"IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.","volume":"110","author":"Burman","year":"2007","journal-title":"Blood"},{"issue":"14","key":"2019111816480549900_B30","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2009-05-219402","article-title":"Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.","volume":"114","author":"Yi","year":"2009","journal-title":"Blood"},{"key":"2019111816480549900_B31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*).","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2019111816480549900_B32","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-199404150-00019","article-title":"T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.","volume":"57","author":"Berger","year":"1994","journal-title":"Transplantation"},{"issue":"5","key":"2019111816480549900_B33","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.174.5.3051","article-title":"Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.","volume":"174","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"issue":"13","key":"2019111816480549900_B34","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1182\/blood-2002-05-1299","article-title":"Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.","volume":"100","author":"Choi","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111816480549900_B35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccr.2012.03.045","article-title":"DNA methylation screening identifies driver epigenetic events of cancer cell survival.","volume":"21","author":"De Carvalho","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111816480549900_B36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2009-12-257253","article-title":"In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.","volume":"116","author":"Choi","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111816480549900_B37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood-2009-03-210393","article-title":"Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.","volume":"115","author":"S\u00e1nchez-Abarca","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2019111816480549900_B38","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.0400380101","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5-6","key":"2019111816480549900_B39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2119\/molmed.2011.00007","article-title":"HDAC inhibition and graft versus host disease.","volume":"17","author":"Choi","year":"2011","journal-title":"Mol Med"},{"issue":"7","key":"2019111816480549900_B40","first-page":"2562","article-title":"Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.","volume":"118","author":"Reddy","year":"2008","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111816480549900_B41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF03189670","article-title":"Pharmacokinetics of the antiviral agent 3-deazaneplanocin A.","volume":"20","author":"Coulombe","year":"1995","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"2019111816480549900_B42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2010-03-271940","article-title":"Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease.","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111816480549900_B43","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI39692","article-title":"PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.","volume":"119","author":"Valenzuela","year":"2009","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111816480549900_B44","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.4049\/jimmunol.1202820","article-title":"Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.","volume":"190","author":"Mochizuki","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"2019111816480549900_B45","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1172\/JCI65477","article-title":"Blockade of individual Notch ligands and receptors controls graft-versus-host disease.","volume":"123","author":"Tran","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111816480549900_B46","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2011-12-395905","article-title":"Control of GVHD: it\u2019s in our DNA!","volume":"119","author":"Chao","year":"2012","journal-title":"Blood"},{"key":"2019111816480549900_B47","doi-asserted-by":"crossref","DOI":"10.1021\/cb400133j","article-title":"An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1.","author":"Konze","year":"2013","journal-title":"ACS Chem Biol"},{"issue":"7427","key":"2019111816480549900_B48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"11","key":"2019111816480549900_B49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nchembio.1084","article-title":"A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.","volume":"8","author":"Knutson","year":"2012","journal-title":"Nat Chem Biol"},{"issue":"52","key":"2019111816480549900_B50","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1073\/pnas.1210371110","article-title":"Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.","volume":"109","author":"Qi","year":"2012","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/25\/4119\/1371988\/4119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/122\/25\/4119\/1371988\/4119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:48:21Z","timestamp":1574095701000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/122\/25\/4119\/32055\/The-histone-methyltransferase-Ezh2-is-a-crucial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,12]]},"references-count":50,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,12,12]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-05-505180","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,12]]}}}